Predicting potent drug combinations by exploiting monotherapy resistance
Predicting potent drug combinations by exploiting monotherapy resistance is a science project.
0 sources
Summary
Predicting potent drug combinations by exploiting monotherapy resistance is a science project[1].
Key Facts
- Predicting potent drug combinations by exploiting monotherapy resistance's instance of is recorded as science project[2].
- Predicting potent drug combinations by exploiting monotherapy resistance began on January 1, 2021[3].
- Predicting potent drug combinations by exploiting monotherapy resistance ended on December 31, 2025[4].
- Among those involved in Predicting potent drug combinations by exploiting monotherapy resistance was eu_cordis_org:999994729[5].
- Predicting potent drug combinations by exploiting monotherapy resistance's short name is recorded as COMBAT-RES[6].
- Predicting potent drug combinations by exploiting monotherapy resistance's budget is recorded as {'unit': 'http://www.wikidata.org/entity/Q4916', 'amount': '+1499991'}[7].
- Predicting potent drug combinations by exploiting monotherapy resistance's funding scheme is recorded as Horizon 2020[8].
Body
When and Where
Predicting potent drug combinations by exploiting monotherapy resistance began on January 1, 2021[3]. It ended on December 31, 2025[4].
Context
Predicting potent drug combinations by exploiting monotherapy resistance's instance of is recorded as science project[2].
Participants
Among those involved in Predicting potent drug combinations by exploiting monotherapy resistance was eu_cordis_org:999994729[5].